BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 88 filers reported holding BRIDGEBIO PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,456,404 | -7.5% | 548,214 | -39.7% | 0.01% | 0.0% |
| Q2 2023 | $15,629,161 | +180814.0% | 909,826 | +74.6% | 0.01% | +66.7% |
| Q1 2023 | $8,639 | +223.3% | 521,077 | +48.6% | 0.00% | +200.0% |
| Q4 2022 | $2,672 | -99.9% | 350,709 | -5.1% | 0.00% | 0.0% |
| Q3 2022 | $3,674,000 | -38.8% | 369,564 | -44.1% | 0.00% | -50.0% |
| Q2 2022 | $6,001,000 | -13.0% | 660,831 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $6,897,000 | +11.2% | 660,579 | +77.7% | 0.00% | 0.0% |
| Q4 2021 | $6,200,000 | -76.6% | 371,706 | -34.3% | 0.00% | -75.0% |
| Q3 2021 | $26,499,000 | -27.0% | 565,374 | -5.0% | 0.01% | -27.3% |
| Q2 2021 | $36,283,000 | +34.7% | 595,188 | +36.1% | 0.01% | +22.2% |
| Q1 2021 | $26,946,000 | +17.5% | 437,438 | +35.7% | 0.01% | +12.5% |
| Q4 2020 | $22,931,000 | +89.4% | 322,475 | -0.1% | 0.01% | +60.0% |
| Q3 2020 | $12,105,000 | +11.4% | 322,641 | -3.2% | 0.01% | +25.0% |
| Q2 2020 | $10,866,000 | -3.6% | 333,219 | -14.3% | 0.00% | -20.0% |
| Q1 2020 | $11,270,000 | -40.0% | 388,648 | -27.5% | 0.01% | -28.6% |
| Q4 2019 | $18,793,000 | +901.8% | 536,163 | +513.7% | 0.01% | +600.0% |
| Q3 2019 | $1,876,000 | – | 87,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |